Biodesix Inc (BDSX): Next-Year EPS Estimate 40.29%
As of 2026-07-27, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 40.29%. Featured in our EPS revision report on 2026-06-29.
On 2026-07-15, analyst consensus for BDSX's next-year EPS growth shifted from 40.28% to 40.29% — a positive change of 0.01 percentage points. The revised estimate has been sustained across 11 subsequent trading sessions. Current-year growth is projected at 36.65%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 40.29%
- EPS growth this year
- 36.65%
- EPS next quarter (est)
- -$0.90
- Last price
- $22.22
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-27 | 40.29% | 36.65% | -$0.90 | $22.22 |
| 2026-07-26 | 40.29% | 36.65% | -$0.90 | $22.00 |
| 2026-07-24 | 40.29% | 36.65% | -$0.90 | $22.00 |
| 2026-07-23 | 40.29% | 36.65% | -$0.90 | $22.32 |
| 2026-07-22 | 40.29% | 36.65% | -$0.90 | $21.39 |
| 2026-07-21 | 40.29% | 36.65% | -$0.90 | $21.14 |
| 2026-07-20 | 40.29% | 36.65% | -$0.90 | $19.81 |
| 2026-07-19 | 40.29% | 36.65% | -$0.90 | $20.19 |
| 2026-07-17 | 40.29% | 36.65% | -$0.90 | $20.19 |
| 2026-07-16 | 40.29% | 36.65% | -$0.90 | $19.96 |
| 2026-07-15 | 40.29% | 36.65% | -$0.90 | $21.00 |
| 2026-07-14 | 40.28% | 36.71% | -$0.90 | $21.13 |
| 2026-07-13 | 40.28% | 36.71% | -$0.90 | $21.42 |
| 2026-07-12 | 40.26% | 36.71% | -$0.90 | $21.42 |
| 2026-07-09 | 40.26% | 36.71% | -$0.90 | $22.15 |
| 2026-07-08 | 40.26% | 36.71% | -$0.90 | $20.15 |
| 2026-07-07 | 40.26% | 36.71% | -$0.90 | $20.34 |
| 2026-07-06 | 40.26% | 36.71% | -$0.90 | $21.85 |
| 2026-07-05 | 40.26% | 36.71% | -$0.90 | $21.99 |
| 2026-07-02 | 40.26% | 36.71% | -$0.90 | $21.99 |
| 2026-07-01 | 40.26% | 36.71% | -$0.90 | $24.50 |
| 2026-06-30 | 40.27% | 36.70% | -$0.90 | $22.55 |
| 2026-06-29 | 40.27% | 36.70% | -$0.90 | $23.81 |
| 2026-06-28 | 40.27% | 36.70% | -$0.90 | $23.34 |
| 2026-06-25 | 40.27% | 36.70% | -$0.90 | $20.04 |
| 2026-06-24 | 40.67% | 36.36% | -$0.90 | $18.67 |
| 2026-06-23 | 40.67% | 36.36% | -$0.90 | $19.16 |
| 2026-06-22 | 40.67% | 36.36% | -$0.90 | $17.35 |
| 2026-06-21 | 40.67% | 36.36% | -$0.90 | $16.81 |
| 2026-06-18 | 40.67% | 36.36% | -$0.90 | $16.81 |
Reports Featuring BDSX
Screen Performance
Aggregate stats across all 1885 tickers our top-EPS-revision screen has flagged over the past 117 days.
- Median return since detection
- +2.2%
- % of tickers in the green
- 55%
- Median return on winners
- +19.3%
- Large revisions captured
- 1125
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Biodesix Inc's next-year EPS growth estimate?▾
As of 2026-07-27, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 40.29%, based on analyst consensus.
When was the latest EPS estimate revision for BDSX?▾
The most recent revision occurred on 2026-07-15, when analysts adjusted the next-year EPS growth estimate from 40.28% to 40.29%.
What sector and industry does Biodesix Inc belong to?▾
Biodesix Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BDSX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Biodesix Inc (BDSX) appears here because it was detected by our daily top-EPS-revision-performer screen.